Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 125 for

Edit search filters
  1. A Study Of ANV419 Alone Or In Combination With Approved Treatment In Patients With Cutaneous Melanoma (OMNIA-1)

    Rochester, MN

  2. MC1R-targeted Alpha-particle Monotherapy And Combination Therapy Trial With Nivolumab In Adults With Advanced Melanoma

    Jacksonville, FL, Rochester, MN

  3. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218)

    Rochester, MN, Jacksonville, FL

  4. Pilot Study Of Antineoplastic

    Rochester, MN

  5. A Study To Better Understand How To Predict And Manage Patients Who Are At High Risk For Developing Rheumatic Immune-related Adverse Events While Receiving Treatment For Melanoma

    Rochester, MN

  6. A Study To Evaluate Immunotherapy And Ovarian Function Among Pre-menopausal Melanoma Survivors

    Jacksonville, FL, Rochester, MN

  7. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

    Rochester, MN

  8. Melanoma Care Barriers In United States Latinx Population

    Scottsdale/Phoenix, AZ

  9. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  10. Olmsted County Healthy Skin Study

    Rochester, MN

.

Mayo Clinic Footer